Integra LifeSciences to Present at Three Conferences in June

/ Source: GlobeNewswire

PLAINSBORO, N.J., May 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in June as follows:

On Tuesday, June 7, 2011 -

At 10:00 AM ET, Mr. Stuart Essig, CEO of Integra, will present at the Jefferies 2011 Global Healthcare Conference in New York City. A live webcast will be available for this conference and a replay will be accessible for 30 days via a link on the investor relations page of our website:

At 10:40 AM PT, Mr. Jack Henneman, Executive Vice President and Chief Financial Officer of Integra, will present at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA. This presentation will not be webcast.

On Thursday, June 23, 2011 at 9:30 AM, Mr. Peter Arduini, President and Chief Operating Officer of Integra, will present at the Wells Fargo 2011 Healthcare Conference in Boston, MA. This presentation will not be webcast.

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Integra LifeSciences Holdings Corporation John B. Henneman, III Executive Vice President Finance and Administration and Chief Financial Officer (609) 275-0500 Investor Relations: Angela Steinway (609) 936-2268